You are here

FogPharma

Fog clears to reveal Parabilis, a rebranded cancer biotech with big name backers

Fierce Pharma

Mon, 10/28/24 - 11:19 am

Parabilis Medicines

FogPharma, Artbio join forces to design a different radiopharma drug

BioPharma Dive

Tue, 05/14/24 - 11:00 pm

radiopharmaceuticals

FogPharma pulls in $145M to support cancer drug research

BioPharma Dive

Mon, 03/4/24 - 11:10 am

FogPharma clears $145M series E thanks to Alexis Borisy, ex-J&J CEO Alex Gorsky

Fierce Biotech

Fri, 03/1/24 - 11:46 am

Mathai Mammen, former J&J executive, to become FogPharma CEO

BioPharma Dive

Thu, 03/30/23 - 10:11 am

FogPharma’s $178M Funding Leads Way as 7 Biotechs Raise Cash for Cancer Drugs

MedCity News

Sun, 11/27/22 - 07:04 pm

Rezo Therapeutics

FogPharma comes through the clearing with a meaty $107M raise for 'undruggable' targets

Fierce Biotech

Tue, 03/2/21 - 10:57 am

undruggable targets